Lancet Respiratory Medicine
Leading citation impact metric from Clarivate Journal Citation Reports
79 papers with at least that number of citations each
State Council for Professorship (HĐGSNN) Scoring
Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)
HĐGSNN Score History
By article publication year| Year | Max Score | Evaluation Details | Source |
|---|---|---|---|
| 2026 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 34.7) | 🔵 Computed |
| 2025 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 32.8) | 🔵 Computed |
| 2024 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 38.7) | 🔵 Computed |
| 2023 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 76.2) | 🔵 Computed |
| 2022 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 102.642) | 🔵 Computed |
| 2021 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 30.7) | 🔵 Computed |
| 2020 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 25.094) | 🔵 Computed |
| 2019 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 22.992) | 🔵 Computed |
| 2018 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 21.466) | 🔵 Computed |
Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.
Aims & Scope
The Lancet Respiratory Medicine delivers comprehensive, clinically-focused coverage on all areas of respiratory medicine and critical care, including but not limited to: COPD, asthma, cystic fibrosis, IPF, pneumonia, influenza, tuberculosis, sarcoidosis, pulmonary hypertension, sleep medicine, respiratory infections, pulmonary vascular disease, lung cancer, tobacco control, thoracic and reconstructive surgery, mesothelioma, and palliative medicine. Continuing in The Lancet's tradition of publishing high-impact content that influences medical practice, each monthly issue of The Lancet Respiratory Medicine contains Original Research, Reviews, Personal Views, Comments, and News. The Lancet Respiratory Medicine is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Original Research is fast-tracked to publication within 8 weeks of submission (on average) and published Online First on www.thelancet.com before appearing in print. Now indexed in PubMed, Journal Citation Reports®, and Scopus, the journal accepts submissions of Original Research, Reviews, Personal Views, and Comments. Visit http://ees.elsevier.com/thelancetrm to learn more about our editorial scope and aims and to submit your manuscript. Gold or Green Open Access is available for research supported by selected funding agencies with whom Elsevier has an agreement. The journal is also freely available to readers in low-to-middle-income countries via the HINARI programme or via IP access at www.thelancet.com. To find out more about The Lancet Respiratory Medicine, visit www.thelancet.com/respiratory.
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Measures cumulative publication volume and citation impact.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
| Category | Index | Rank | Quartile |
|---|---|---|---|
CRITICAL CARE MEDICINE | JCRSCIE | 1/66 | Q1 |
RESPIRATORY SYSTEM | JCRSCIE | 1/107 | Q1 |
CRITICAL CARE MEDICINE | JCISCIE | 1/66 | Q1 |
RESPIRATORY SYSTEM | JCISCIE | 1/107 | Q1 |
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
| Year | Impact Factor | Articles / Year | Total Citations |
|---|---|---|---|
| 2026 | — | 175 | 194 |
| 2025 | 32.8 | 265 | 3,077 |
| 2024 | 38.7 | 241 | 4,410 |
| 2023 | 76.2 | 272 | 8,404 |
| 2022 | 102.642 | 307 | 14,324 |
| 2021 | 30.7 | 387 | 26,478 |
| 2020 | 25.094 | 354 | 69,582 |
| 2019 | 22.992 | 287 | 21,770 |
| 2018 | 21.466 | 309 | 21,715 |
| 2017 | — | 290 | 17,230 |
| 2016 | — | 341 | 19,648 |
| 2015 | — | 336 | 19,269 |
Journal Metrics & Citation Visualizations
Impact Factor Trend (2018–2024)
Clarivate IF trend for Lancet Respiratory Medicine
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics